Pfizer standalone net profit declines 83.72% in the June 2022 quarter

Sales decline 20.86% to Rs 592.90 crore

Net profit of Pfizer declined 83.72% to Rs 32.55 crore in the quarter ended June 2022 as against Rs 199.91 crore during the previous quarter ended June 2021. Sales declined 20.86% to Rs 592.90 crore in the quarter ended June 2022 as against Rs 749.17 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales592.90749.17 -21 OPM %32.3638.14 -PBDT206.23295.73 -30 PBT179.72268.73 -33 NP32.55199.91 -84

Powered by Capital Market - Live News